Plunkett Research Online: Immage Biotherapeutics

IMMAGE BIOTHERAPEUTICS (IMMG:GREY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Immage Biotherapeutics Corp is a biotechnology company developing cancer immunotherapy through the rapid and efficient development of cutting-edge immunotherapy candidates using bioinformatics and outsourced laboratory resources......



Immage Biotherapeutics
Ticker: IMMG
Exchange: GREY
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 866 692-2939
Fax:
Address: 10411 Motor City
Bethesda, MD 20817 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Vaccines, Skin Replacement Products and Biologicals Manufacturing
Contacts Description
Zhi MouCEO/Director/President
Elton NormanCFO/Chief Accounting Officer/Director
See More
Immage Biotherapeutics Corp is a biotechnology company developing cancer immunotherapy through the rapid and efficient development of cutting-edge immunotherapy candidates using bioinformatics and outsourced laboratory resources......See More See More

Auditor: MaloneBailey, LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: